Opioid Use Disorder Market by Drug - Global Industry Analysis & Forecast to 2027
Published On : July 2019 Pages : 154 Category: Pharmaceuticals Report Code : HC074439
Opioid Use Disorder Market by Drug (Methadone, Buprenorphine, Naltrexone) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Opioid Use Disorder Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Narcotic Use Disorder (OUD) is an chronic issue related with prolonged, compulsive, and repeated administration of opioids. There are two kinds of patients experiencing OUD: patients who are dependent on non-therapeutic opioids and patients dependent on medical narcotics.
Drivers and Restraints
Expansion in opioid epidemic in the United States combined with foundation of government strategies to control the emergency is driving the market. Pipeline treatments are concentrating on reformulations just as novel system of activity to battle opioid addiction. The commercialization of these specialists is anticipated to be one of the main drivers of the opioid use disorder market over the gauge time frame.
Regional Insights
North America was the biggest income producing locale in 2018 and is foreseen to demonstrate a similar pattern over the figure time frame.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Indivior
- Titan Pharmaceuticals
- Teva Pharmaceuticals
- Orexo
- Omeros
- Alkermes
- Hikma Pharmaceuticals
- MediciNova
- Camurus
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Opioid Use Disorder Market, By Drug, Estimates and Forecast, 2017-2027 ($Million)
o Methadone
o Buprenorphine
o Naltrexone
· Opioid Use Disorder Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Indivior
o Titan Pharmaceuticals
o Teva Pharmaceuticals
o Orexo
o Omeros
o Alkermes
o Hikma Pharmaceuticals
o MediciNova
o Camurus
· Opioid Use Disorder Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Opioid Use Disorder Market, By Country
o U.S. Opioid Use Disorder Market
o Canada Opioid Use Disorder Market
o Mexico Opioid Use Disorder Market
o Europe
§ Europe Opioid Use Disorder Market, By Country
· Germany Opioid Use Disorder Market
o UK Opioid Use Disorder Market
o France Opioid Use Disorder Market
o Russia Opioid Use Disorder Market
o Italy Opioid Use Disorder Market
o Rest of Europe Opioid Use Disorder Market
o Asia-Pacific
§ Asia-Pacific Opioid Use Disorder Market, By Country
o China Opioid Use Disorder Market
o Japan Opioid Use Disorder Market
o South Korea Opioid Use Disorder Market
o India Opioid Use Disorder Market
o Southeast Asia Opioid Use Disorder Market
o Rest of Asia-Pacific Opioid Use Disorder Market
o South America
§ South America Opioid Use Disorder Market
o Brazil Opioid Use Disorder Market
o Argentina Opioid Use Disorder Market
o Columbia Opioid Use Disorder Market
o Rest of South America Opioid Use Disorder Market
o Middle East and Africa
§ Middle East and Africa Opioid Use Disorder Market
o Saudi Arabia Opioid Use Disorder Market
o UAE Opioid Use Disorder Market
o Egypt Opioid Use Disorder Market
o Nigeria Opioid Use Disorder Market
o South Africa Opioid Use Disorder Market
o Rest of MEA Opioid Use Disorder Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Opioid Use Disorder Market, By Drug
5.1. Introduction
5.2. Global Opioid Use Disorder Revenue and Market Share by Drug (2017-2027)
5.2.1. Global Opioid Use Disorder Revenue and Revenue Share by Drug (2017-2027)
5.3. Methadone
5.3.1. Global Methadone Revenue and Growth Rate (2017-2027)
5.4. Buprenorphine
5.4.1. Global Buprenorphine Revenue and Growth Rate (2017-2027)
5.5. Naltrexone
5.5.1. Global Naltrexone Revenue and Growth Rate (2017-2027)
6. Opioid Use Disorder Market, By Region
6.1. Introduction
6.2. Global Opioid Use Disorder Revenue and Market Share by Regions
6.2.1. Global Opioid Use Disorder Revenue by Regions (2017-2027)
6.3. North America Opioid Use Disorder by Countries
6.3.1. North America Opioid Use Disorder Revenue and Growth Rate (2017-2027)
6.3.2. North America Opioid Use Disorder Revenue (Million USD) by Countries (2017-2027)
6.3.3. United States
6.3.3.1. United States Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.4. Canada
6.3.4.1. Canada Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.5. Mexico
6.3.5.1. Mexico Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Opioid Use Disorder by Countries
6.4.1. Europe Opioid Use Disorder Revenue and Growth Rate (2017-2027)
6.4.2. Europe Opioid Use Disorder Revenue (Million USD) by Countries (2017-2027)
6.4.3. Germany
6.4.3.1. Germany Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.4. France
6.4.4.1. France Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.5. UK
6.4.5.1. UK Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. Russia
6.4.6.1. Russia Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. Italy
6.4.7.1. Italy Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Rest of Europe
6.4.8.1. Rest of Europe Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific Opioid Use Disorder by Countries
6.5.1. Asia-Pacific Opioid Use Disorder Revenue and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Opioid Use Disorder Revenue (Million USD) by Countries (2017-2027)
6.5.3. China
6.5.3.1. China Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.4. Japan
6.5.4.1. Japan Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.5. Korea
6.5.5.1. Korea Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. India
6.5.6.1. India Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.7. Southeast Asia
6.5.7.1. Southeast Asia Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. Rest of Asia-Pacific
6.5.8.1. Rest of Asia-Pacific Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America Opioid Use Disorder by Countries
6.6.1. South America Opioid Use Disorder Revenue and Growth Rate (2017-2027)
6.6.2. South America Opioid Use Disorder Revenue (Million USD) by Countries (2017-2027)
6.6.3. Brazil
6.6.3.1. Brazil Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.4. Argentina
6.6.4.1. Argentina Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.5. Columbia
6.6.5.1. Columbia Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Rest of South America
6.6.6.1. Rest of South America Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa Opioid Use Disorder by Countries
6.7.1. Middle East and Africa Opioid Use Disorder Revenue and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Opioid Use Disorder Revenue (Million USD) by Countries (2017-2027)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.4. United Arab Emirates
6.7.4.1. United Arab Emirates Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.5. Egypt
6.7.5.1. Egypt Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. Nigeria
6.7.6.1. Nigeria Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. South Africa
6.7.7.1. South Africa Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Turkey
6.7.8.1. Turkey Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. Rest of Middle East and Africa
6.7.9.1. Rest of Middle East and Africa Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. Indivior
7.1.1. Business Overview
7.1.2. Service Portfolio
7.1.3. Strategic Developments
7.1.4. Financial Overview
7.2. Titan Pharmaceuticals
7.2.1. Business Overview
7.2.2. Service Portfolio
7.2.3. Strategic Developments
7.2.4. Financial Overview
7.3. Teva Pharmaceuticals
7.3.1. Business Overview
7.3.2. Service Portfolio
7.3.3. Strategic Developments
7.3.4. Financial Overview
7.4. Orexo
7.4.1. Business Overview
7.4.2. Service Portfolio
7.4.3. Strategic Developments
7.4.4. Financial Overview
7.5. Omeros
7.5.1. Business Overview
7.5.2. Service Portfolio
7.5.3. Strategic Developments
7.5.4. Financial Overview
7.6. Alkermes
7.6.1. Business Overview
7.6.2. Service Portfolio
7.6.3. Strategic Developments
7.6.4. Financial Overview
7.7. Hikma Pharmaceuticals
7.7.1. Business Overview
7.7.2. Service Portfolio
7.7.3. Strategic Developments
7.7.4. Financial Overview
7.8. MediciNova
7.8.1. Business Overview
7.8.2. Service Portfolio
7.8.3. Strategic Developments
7.8.4. Financial Overview
7.9. Camurus
7.9.1. Business Overview
7.9.2. Service Portfolio
7.9.3. Strategic Developments
7.9.4. Financial Overview
8. Opioid Use Disorder Market Forecast (2017-2027)
8.1. Global Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2027)
8.2. Opioid Use Disorder Market Forecast by Regions (2017-2027)
8.2.1. North America Opioid Use Disorder Market Forecast (2017-2027)
8.2.1.1. United States Opioid Use Disorder Market Forecast (2017-2027)
8.2.1.2. Canada Opioid Use Disorder Market Forecast (2017-2027)
8.2.1.3. Mexico Opioid Use Disorder Market Forecast (2017-2027)
8.2.2. Europe Opioid Use Disorder Market Forecast (2017-2027)
8.2.2.1. Germany Opioid Use Disorder Market Forecast (2017-2027)
8.2.2.2. France Opioid Use Disorder Market Forecast (2017-2027)
8.2.2.3. UK Opioid Use Disorder Market Forecast (2017-2027)
8.2.2.4. Russia Opioid Use Disorder Market Forecast (2017-2027)
8.2.2.5. Italy Opioid Use Disorder Market Forecast (2017-2027)
8.2.2.6. Rest of Europe Opioid Use Disorder Market Forecast (2017-2027)
8.2.3. Asia-Pacific Opioid Use Disorder Market Forecast (2017-2027)
8.2.3.1. China Opioid Use Disorder Market Forecast (2017-2027)
8.2.3.2. Japan Opioid Use Disorder Market Forecast (2017-2027)
8.2.3.3. Korea Opioid Use Disorder Market Forecast (2017-2027)
8.2.3.4. India Opioid Use Disorder Market Forecast (2017-2027)
8.2.3.5. Southeast Asia Opioid Use Disorder Market Forecast (2017-2027)
8.2.3.6. Rest of Asia-Pacific Opioid Use Disorder Market Forecast (2017-2027)
8.2.4. South America Opioid Use Disorder Market Forecast (2017-2027)
8.2.4.1. Brazil Opioid Use Disorder Market Forecast (2017-2027)
8.2.4.2. Argentina Opioid Use Disorder Market Forecast (2017-2027)
8.2.4.3. Columbia Opioid Use Disorder Market Forecast (2017-2027)
8.2.4.4. Rest of South America Opioid Use Disorder Market Forecast (2017-2027)
8.2.5. Middle East and Africa Opioid Use Disorder Market Forecast (2017-2027)
8.2.5.1. Saudi Arabia Opioid Use Disorder Market Forecast (2017-2027)
8.2.5.2. United Arab Emirates Opioid Use Disorder Market Forecast (2017-2027)
8.2.5.3. Egypt Opioid Use Disorder Market Forecast (2017-2027)
8.2.5.4. Nigeria Opioid Use Disorder Market Forecast (2017-2027)
8.2.5.5. South Africa Opioid Use Disorder Market Forecast (2017-2027)
8.2.5.6. Turkey Opioid Use Disorder Market Forecast (2017-2027)
8.2.5.7. Rest of Middle East and Africa Opioid Use Disorder Market Forecast (2017-2027)
8.3. Opioid Use Disorder Market Forecast by Drug (2017-2027)
8.3.1. Opioid Use Disorder Forecast by Drug (2017-2027)
8.3.2. Opioid Use Disorder Market Share Forecast by Drug (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Opioid Use Disorder Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Opioid Use Disorder Revenue and Revenue Share by Drug (2017-2018)
Figure Global Methadone Revenue and Growth Rate (2017-2018)
Figure Global Buprenorphine Revenue and Growth Rate (2017-2018)
Figure Global Naltrexone Revenue and Growth Rate (2017-2018)
Table Global Opioid Use Disorder Revenue by Regions (2017-2018)
Figure North America Opioid Use Disorder Growth Rate (2017-2018)
Figure North America Opioid Use Disorder Revenue and Growth Rate (2017-2018)
Figure North America Opioid Use Disorder by Countries (2017-2018)
Figure North America Opioid Use Disorder Revenue (Million USD) by Countries (2017-2018)
Figure United States Opioid Use Disorder Growth Rate (2017-2018)
Figure United States Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Opioid Use Disorder Growth Rate (2017-2018)
Figure Canada Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Opioid Use Disorder Growth Rate (2017-2018)
Figure Mexico Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Opioid Use Disorder Growth Rate (2017-2018)
Figure Europe Opioid Use Disorder Revenue and Growth Rate (2017-2018)
Figure Europe Opioid Use Disorder by Countries (2017-2018)
Figure Europe Opioid Use Disorder Revenue (Million USD) by Countries (2017-2018)
Figure Germany Opioid Use Disorder Growth Rate (2017-2018)
Figure Germany Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Opioid Use Disorder Growth Rate (2017-2018)
Figure France Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Opioid Use Disorder Growth Rate (2017-2018)
Figure UK Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Opioid Use Disorder Growth Rate (2017-2018)
Figure Russia Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Opioid Use Disorder Growth Rate (2017-2018)
Figure Italy Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Opioid Use Disorder Growth Rate (2017-2018)
Figure Rest of Europe Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Opioid Use Disorder Growth Rate (2017-2018)
Figure Asia-Pacific Opioid Use Disorder Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Opioid Use Disorder by Countries (2017-2018)
Figure Asia-Pacific Opioid Use Disorder Revenue (Million USD) by Countries (2017-2018)
Figure China Opioid Use Disorder Growth Rate (2017-2018)
Figure China Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Opioid Use Disorder Growth Rate (2017-2018)
Figure Japan Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Opioid Use Disorder Growth Rate (2017-2018)
Figure Korea Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Opioid Use Disorder Growth Rate (2017-2018)
Figure India Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Opioid Use Disorder Growth Rate (2017-2018)
Figure Southeast Asia Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Opioid Use Disorder Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Opioid Use Disorder Growth Rate (2017-2018)
Figure South America Opioid Use Disorder Revenue and Growth Rate (2017-2018)
Figure South America Opioid Use Disorder by Countries (2017-2018)
Figure South America Opioid Use Disorder Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Opioid Use Disorder Growth Rate (2017-2018)
Figure Brazil Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Opioid Use Disorder Growth Rate (2017-2018)
Figure Argentina Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Opioid Use Disorder Growth Rate (2017-2018)
Figure Columbia Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Opioid Use Disorder Growth Rate (2017-2018)
Figure Rest of South America Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Opioid Use Disorder Growth Rate (2017-2018)
Figure Middle East and Africa Opioid Use Disorder Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Opioid Use Disorder by Countries (2017-2018)
Figure Middle East and Africa Opioid Use Disorder Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Opioid Use Disorder Growth Rate (2017-2018)
Figure Saudi Arabia Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Opioid Use Disorder Growth Rate (2017-2018)
Figure United Arab Emirates Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Opioid Use Disorder Growth Rate (2017-2018)
Figure Egypt Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Opioid Use Disorder Growth Rate (2017-2018)
Figure Nigeria Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Opioid Use Disorder Growth Rate (2017-2018)
Figure South Africa Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Opioid Use Disorder Growth Rate (2017-2018)
Figure Turkey Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Opioid Use Disorder Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2017-2018)
Table Indivior Opioid Use Disorder Financial Overview
Table Titan Pharmaceuticals Opioid Use Disorder Financial Overview
Table Teva Pharmaceuticals Opioid Use Disorder Financial Overview
Table Orexo Opioid Use Disorder Financial Overview
Table Omeros Opioid Use Disorder Financial Overview
Table Alkermes Opioid Use Disorder Financial Overview
Table Hikma Pharmaceuticals Opioid Use Disorder Financial Overview
Table MediciNova Opioid Use Disorder Financial Overview
Table Camurus Opioid Use Disorder Financial Overview
Figure Global Opioid Use Disorder Revenue (Millions USD) and Growth Rate (2018-2025)
Table Opioid Use Disorder Market Forecast by Regions (2018-2025)
Figure North America Opioid Use Disorder Market Forecast (2018-2025)
Figure United States Opioid Use Disorder Market Forecast (2018-2025)
Figure Canada Opioid Use Disorder Market Forecast (2018-2025)
Figure Mexico Opioid Use Disorder Market Forecast (2018-2025)
Figure Europe Opioid Use Disorder Market Forecast (2018-2025)
Figure Germany Opioid Use Disorder Market Forecast (2018-2025)
Figure France Opioid Use Disorder Market Forecast (2018-2025)
Figure UK Opioid Use Disorder Market Forecast (2018-2025)
Figure Russia Opioid Use Disorder Market Forecast (2018-2025)
Figure Italy Opioid Use Disorder Market Forecast (2018-2025)
Figure Rest of Europe Opioid Use Disorder Market Forecast (2018-2025)
Figure Asia-Pacific Opioid Use Disorder Market Forecast (2018-2025)
Figure China Opioid Use Disorder Market Forecast (2018-2025)
Figure Japan Opioid Use Disorder Market Forecast (2018-2025)
Figure Korea Opioid Use Disorder Market Forecast (2018-2025)
Figure India Opioid Use Disorder Market Forecast (2018-2025)
Figure Southeast Asia Opioid Use Disorder Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Opioid Use Disorder Market Forecast (2018-2025)
Figure South America Opioid Use Disorder Market Forecast (2018-2025)
Figure Brazil Opioid Use Disorder Market Forecast (2018-2025)
Figure Argentina Opioid Use Disorder Market Forecast (2018-2025)
Figure Columbia Opioid Use Disorder Market Forecast (2018-2025)
Figure Rest of South America Opioid Use Disorder Market Forecast (2018-2025)
Figure Middle East and Africa Opioid Use Disorder Market Forecast (2018-2025)
Figure Saudi Arabia Opioid Use Disorder Market Forecast (2018-2025)
Figure United Arab Emirates Opioid Use Disorder Market Forecast (2018-2025)
Figure Egypt Opioid Use Disorder Market Forecast (2018-2025)
Figure Nigeria Opioid Use Disorder Market Forecast (2018-2025)
Figure South Africa Opioid Use Disorder Market Forecast (2018-2025)
Figure Turkey Opioid Use Disorder Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Opioid Use Disorder Market Forecast (2018-2025)
Figure Global Opioid Use Disorder Forecast by Drug (2018-2025)
Figure Global Opioid Use Disorder Market Share Forecast by Drug (2018-2025)
Figure Global Opioid Use Disorder Forecast by Drug (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|